Critical Illness definitions are changing. This is what you should know.

Did you know? Critical illness definitions will change with effect from 1 October 2025. Here is a summary of the changes, and what you can expect next.

iFAST Insurance Team
iFAST Insurance Team 16 Sep 2025 9182 Views
Critical Illness definitions are changing. This is what you should know.

What is critical illness insurance?

  • Critical illness insurance provides a lump sum pay-out in the event of a specified critical illness. This could be for early, intermediate, or advanced stage critical illnesses.
  • Such critical illness plans would usually include coverage for the 37 standard critical illnesses as defined by the Life Insurance Association Singapore (LIA). These standard definitions have been adopted for use by the industry since 2003.
  • Critical illness insurance tends to offer coverage for more than the 37 standard critical illnesses and may cover for up to 161 medical conditions depending on the plan chosen. Reach out to us here if you would like to find out more.

A summary of the changes:

The Life Insurance Association Singapore (LIA) has put out a standard list of definitions for critical illnesses since 2003. These standard definitions are used by the insurance industry and will be reviewed every three years to ensure that the critical illness definitions are kept relevant.

From 1 October 2025, Insurers are expected to align the critical illness (CI) definitions in their policies with the LIA CI Framework 2024. Seven critical illness definitions and two header names have been revised to provide clarity on the scope of coverage, accurately reflect the circumstances whereby a claim can be made, and ensure that coverage is kept up to date with advancements in medical technology. These changes that will take effect no later than 1 October 2025, will apply to new critical illness policies and leave existing policies unaffected.

Critical illnesses with revised definitions in the LIA CI Framework 2024:

Condition

Changes

1.

Major Cancer

PitNET is a recently recognised term, acknowledged by the WHO in 2022. For clarity, we included the exclusion of PitNET along with the exclusion of Neuroendocrine tumors. PitNET covers pituitary adenoma which was not classified previously as Cancer and never intended to be covered under Major Cancer definition.

2.

Coma

Self-inflicted injuries are not intended to be covered. Added exclusion “or self-inflicted injuries” for clarity.

3.

Deafness (Irreversible Loss of Hearing)

Expanded the meaning on what “Total” means for greater clarity, and added Irreversible meaning “40 decibels or lower”.

4.

Open-Heart Heart Valve Surgery

Revise definition heading to provide clarity of the coverage scope (i.e. not requiring opening of chest wall but only opening of the heart).

Also added definition for Open Heart Surgery to provide clarity to the scope of this coverage. As long as the surgery requires incision to the heart for the direct visual replacement or repair of heart valve, this definition is fulfilled. This revised definition no longer requires opening of chest wall.

Exclusions used to ensure clarity of coverage that is not in scope (which were similarly not covered under 2019 definition):

-         The operation or procedure performed via endoscopic or keyhole surgery.

-         The operation or procedure performed via catheterisation

5.

Terminal Illness

Change of definition to more accurately specify the eligible circumstances for a claim under Terminal Illness.

6.

Persistent Vegetative State (Apallic Syndrome)

As it was never the intent to restrict the diagnosis to be made only to “approved hospital”, have removed “holding such appointment at an approved hospital” to add clarity.

7.

Other Serious Coronary Artery Disease

Revised the definition to provide a clearer understanding of the real intention and requirements before a claim is admitted

Critical illnesses with revised titles:

New header

Changes

1.

Surgery to Aorta

From Open Chest Surgery to Aorta to Surgery to Aorta

2.

Open Chest Heart Valve Surgery

From Open Chest Heart Valve Surgery to Open-Heart Heart Valve Surgery

Will my insurance cost more with these revised critical illness definitions?

This revision of definition(s) is not expected to result in an increase of premiums. However, insurers have no obligation to keep premiums status quo. Some insurers may also choose to take this opportunity to revise the benefits offered in their plans and these revisions may then result in premium adjustments.

How much will a critical illness insurance plan cost?

While premiums vary according to an individual’s needs and circumstances, we generated quotations for six different insurers, keeping the conditions for coverage the same among the six. This was what we found:

  • The cost of a critical illness insurance plan for $200,000 early critical illness coverage can be relatively affordable with this kept below $2,000 premiums a year for those age 40 and below.
Illustrated premiums for a $200,000 early critical illness plan for a non-smoking individual:

Age 30

Age 40

Age 50

Male

From $1,117.85

From $1,820.95

From $3,181.50

Female

From $1,223.40

From $1,828.10

From $2,904.20

Premiums shown are indicative and accurate as of 8 September 2025. For illustration purposes only. Specified age in this table is on an age last birthday (ALB) basis, and coverage is given for up to age 74 ALB unless otherwise specified.

  • Most insurers have revised their critical illness definitions to align with the LIA Critical Illness Framework 2024. These changes will only affect newly taken up policies and does not affect existing policies. Reach out to us here if you would like to find out more.
Revision of CI definitions to LIA Critical Illness Framework 2024:

Insurer

Changes will take effect from

Etiqa

25 September 2025

Income

1 October 2025

Manulife

14 September 2025

Singlife

27 August 2025

Tokio Marine

1 October 2025

An alternative to a standalone critical illness plan: iFAST Digital Term with Cancer 360 or Cancer Plus rider

If you already have a critical illness plan, or are looking for a more affordable alternative, iFAST Digital Term could be a suitable option.

With iFAST Digital Term, you may choose to enhance your coverage with optional cancer riders – i.e. the Cancer360 or Cancer Plus rider. These riders provide coverage for early, intermediate and/or advanced stage cancer with pay-outs given in addition to your base coverage.

As this rider pays on an additional basis, claims paid out for Cancer360 or Cancer Plus rider will not reduce the sum assured of your base plan.

  • Base plan for iFAST Digital Term covers for death and terminal illness only.
  • Cancer 360 rider covers for all stages of cancer with additional pay-out provided. This means that a claim made from this rider will not reduce the sum assured of your core plan.
  • Cancer Plus rider offers up to S$1 million coverage for late-stage cancer with additional pay-out provided. This means that a claim made from this rider will not reduce the sum assured of your core plan.

Illustrated premiums for a $50,000 base iFAST Digital Term coverage + $200,000 early critical illness (Cancer360 rider) for a non-smoking individual:

Age 30

Age 40

Age 50

Male

$103.00

$182.50

$395.50

Female

$169.50

$481.50

$1,058.00

Figures are for illustration purposes only and are accurate as of 8 September 2025.
iFAST Digital Term is a yearly renewable term plan with premiums based on life assured’s attained age at renewal. Plan can be renewed up to 70 years old (age last birthday). Cancer360 is a cancer rider and will only pay-out in the event of a claim for cancer.

Click here to get a free iFAST Digital Term quote, and make your purchase from the comforts of your home. 


Read also,


Available Products on FSMOne Insurance

Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial)

from AIG, Allianz, Cigna, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Henner, Income, Manulife, MSIG, Raffles Health Insurance, Singlife, Sompo, Tokio Marine, and QBE.

*Please check with our team if the product you want is available on FSMOne Insurance


Information obtained from:
https://www.lia.org.sg/media/4549/lia-ci-framework-2024-part-1-of-4.pdf
https://www.lia.org.sg/media/4551/lia-ci-framework-2024-part-3-of-4-comparison-of-lia-definitions-2019-and-2024.pdf
Information retrieved on 8 September 2025.


Disclaimer:
^Profile: Age 30, non-smoker female for $50,000 base iFAST Digital Term coverage.
All materials and content found in this article are strictly for information purposes only and should not be considered as an offer or solicitation to transact in any product. This article is not a contract of insurance.
Insurance products are underwritten by the respective insurance partners and distributed by iFAST Financial Pte Ltd (“iFAST”). You are advised to review the specific terms, conditions and exclusions in the relevant policy contract.
You are advised to read the key product documents, including (but not limited to) the product summary, before deciding whether the product is suitable for you. You should consider carefully if the products you are purchasing are suitable for your financial objectives, experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of a product, please seek advice from a financial adviser before making a decision to purchase the product.
While iFAST and its third-party providers strive to provide accurate and timely information, there may be inadvertent omissions, inaccuracies, and typographical errors. Opinions expressed herein are subjected to change without notice. More information on iFAST Digital Term can be found here: https://secure.fundsupermart.com/fsmone/insurance/ifast-digital-term.
The comparisons and opinions provided are based on publicly available data/information and are intended to provide a general overview of the insurance products discussed. These comparisons do not cover all available products and may not fully illustrate every aspect of the products discussed.
Purchasing a life insurance policy is a long-term commitment, and early termination may involve significant costs. The surrender value, if any, may be zero or less than the total premiums paid.
This advertisement has not been reviewed by the Monetary Authority of Singapore.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.